Ameluz 78 mg/g, Gel

7680656930017 CH-65693 Gel

Associated product:

AMELUZ gel 78 mg/g tb 2 g
Ameluz 78 mg/g, Gel
Ameluz 78 mg/g, Gel
Ameluz 78 mg/g, Gel
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
17/05/2022
Summary of Product Characteristics
Français
17/05/2022
Summary of Product Characteristics
Italien
17/05/2022

Detailed composition

Substance Quantity Type Category
(N/A)
78.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.36 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 226.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2016

Authorization holder

Louis Widmer AG

8952 Schlieren

Authorization information

Swissmedic authorization number
65693
Drug name
Ameluz, Gel
Galenic form
GELK
ATC Code
L01XD04
Authorization status
Z
Dispensing category
B
First authorization
26/11/2015
Authorization expiration date
31/12/9999
IT Number
07.16.4.
Domain
Human medicine
Field of application
Aktinische Keratosen, superfizielles und/oder noduläres Basaliom

Package details

Description (FR)
AMELUZ gel 78 mg/g tb 2 g
Description (DE)
AMELUZ Gel 78 mg/g Tb 2 g
Market launch
26/11/2015
Narcotic (BTM)
No